Medac Gesellschaft Für Klinische Spezialpräparate Mbh competitive analysis

Explore patent oppositions filed by Medac Gesellschaft Für Klinische Spezialpräparate Mbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 11, 2022
Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAMar 22, 2021
Cabazitaxel And Its Use For Treating CancerAVENTIS PHARMASep 18, 2020

Explore Medac Gesellschaft Für Klinische Spezialpräparate Mbh's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 20, 2019Method For Producing A Freeze-Dried Pharmaceutical Composition Containing Mitomycin C1

Latest PTAB cases involving Medac Gesellschaft Für Klinische Spezialpräparate Mbh

Discover the latest PTAB cases involving Medac Gesellschaft Für Klinische Spezialpräparate Mbh, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 26, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Medac Gesellschaft Für Klinische Spezialpräparate Mbh

IPR2016-01370Jul 20, 2016KOIOS PHARMACEUTICALSMEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBHFinal Written Decision
IPR2016-00649Feb 22, 2016FRONTIER THERAPEUTICSMEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBHTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Medac Gesellschaft Für Klinische Spezialpräparate Mbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE MBH41 - 2
COUGAR BIOTECHNOLOGY - 24 - -
FRONTIER THERAPEUTICS - - 1 -
HOLLATZ6 - - -